BNY Mellon Long-Term Global Equity Fund USD X AccRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | 16.3 | 8.6 | |
+/-Cat | - | - | - | 0.3 | -2.8 | |
+/-B’mrk | - | - | - | -6.0 | -8.3 | |
Category: Global Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar Gbl Growth TME ... |
Key Stats | ||
NAV 20/11/2024 | USD 1.42 | |
Day Change | 0.03% | |
Morningstar Category™ | Global Large-Cap Growth Equity | |
ISIN | IE00BZ7MD267 | |
Fund Size (Mil) 31/10/2024 | EUR 1586.21 | |
Share Class Size (Mil) 20/11/2024 | USD 0.01 | |
Max Initial Charge | - | |
Ongoing Charge 02/08/2024 | 0.08% |
Investment Objective: BNY Mellon Long-Term Global Equity Fund USD X Acc |
The objective of the Sub-Fund is to achieve long-term capital appreciation through investing primarily (meaning at least three-quarters of the Sub-Fund’s total assets) in a portfolio of equity and equity related securities of companies located throughout the world. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Roy Leckie 04/04/2008 | ||
Charles Macquaker 04/04/2008 | ||
Click here to see others | ||
Inception Date 02/09/2022 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World NR EUR | Morningstar Gbl Growth TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BNY Mellon Long-Term Global Equity Fund USD X Acc | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Taiwan Semiconductor Manufacturi... | Technology | 3.90 |
Microsoft Corp | Technology | 3.70 |
Novo Nordisk AS Class B | Healthcare | 3.53 |
Amphenol Corp Class A | Technology | 3.16 |
Linde PLC | Basic Materials | 2.97 |
Increase Decrease New since last portfolio | ||
BNY Mellon Long-Term Global Equity Fund USD X Acc |